Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
29.37
+0.50 (1.73%)
At close: Nov 13, 2026, 4:00 PM EST
29.90
+0.53 (1.80%)
After-hours: Nov 13, 2026, 5:31 PM EST
Amphastar Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 98.96 | 98.09 | 159.52 | 137.55 | 91.39 | 62.12 |
Depreciation & Amortization | 66.68 | 63.2 | 57.21 | 41.78 | 28.28 | 26.53 |
Other Amortization | 3.48 | 3.36 | 6.03 | 11.4 | 0.47 | 0.22 |
Loss (Gain) From Sale of Assets | 0.44 | 0.04 | 0.01 | 0.48 | 0.14 | -13.24 |
Asset Writedown & Restructuring Costs | - | - | - | 2.7 | - | - |
Loss (Gain) From Sale of Investments | -3.51 | 2.49 | -2.79 | 5.33 | -2.2 | 0.03 |
Loss (Gain) on Equity Investments | - | - | 0.57 | 1.98 | 1.18 | 0.21 |
Stock-Based Compensation | 29.58 | 27.28 | 24.37 | 20.24 | 17.86 | 18.69 |
Other Operating Activities | 27.63 | 27.63 | -16.98 | -13.74 | -15.75 | 5.39 |
Change in Accounts Receivable | -35.73 | -6.37 | -21.67 | -26.09 | -10.13 | -14.92 |
Change in Inventory | 11.3 | -21.06 | -48.8 | -1.72 | -11.75 | 1.26 |
Change in Accounts Payable | -15.22 | -4.56 | 63.56 | 13.24 | -0.74 | 3.63 |
Change in Income Taxes | -3.96 | -24.84 | 6.83 | -3.32 | -4.56 | 8.35 |
Change in Other Net Operating Assets | -4.31 | -9.14 | -14.48 | -6.32 | -5.01 | -0.27 |
Operating Cash Flow | 175.33 | 156.12 | 213.39 | 183.5 | 89.18 | 97.99 |
Operating Cash Flow Growth | 15.14% | -26.84% | 16.29% | 105.77% | -8.99% | 71.12% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -36.31 | -34.88 | -41.04 | -38.17 | -24.03 | -27.46 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.42 | - |
Cash Acquisitions | - | - | -129 | -506.41 | - | - |
Sale (Purchase) of Intangibles | -94.5 | -2.25 | - | - | - | - |
Investment in Securities | 36.98 | -28.84 | 49.23 | -105.93 | -7.79 | 1.4 |
Other Investing Activities | -2.57 | -4.36 | -4.12 | 1.39 | -1.37 | -2.61 |
Investing Cash Flow | -96.4 | -70.33 | -124.93 | -649.12 | -32.78 | -28.67 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 6.22 | 18.43 | 845 | - | 70 |
Long-Term Debt Repaid | - | -0.22 | -8.26 | -318.66 | -1.78 | -37.9 |
Net Debt Issued (Repaid) | -0.42 | 5.99 | 10.17 | 526.34 | -1.78 | 32.1 |
Issuance of Common Stock | 5.68 | 2.86 | - | 10.97 | 15.66 | 15.93 |
Repurchase of Common Stock | -95.66 | -75.59 | -90.31 | -58.14 | -39.91 | -28.87 |
Other Financing Activities | -0.01 | -0.69 | -0.82 | -25.08 | -0.41 | -56.17 |
Financing Cash Flow | -90.41 | -67.43 | -80.95 | 454.09 | -26.44 | -37.02 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.2 | 0.21 | -0.19 | -0.28 | -0.22 | -0.22 |
Net Cash Flow | -11.68 | 18.57 | 7.31 | -11.8 | 29.75 | 32.08 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 139.02 | 121.23 | 172.35 | 145.34 | 65.15 | 70.54 |
Free Cash Flow Growth | 22.75% | -29.66% | 18.58% | 123.09% | -7.64% | 201.30% |
Free Cash Flow Margin | 18.64% | 16.84% | 23.54% | 22.55% | 13.06% | 16.11% |
Free Cash Flow Per Share | 3.07 | 2.51 | 3.31 | 2.74 | 1.24 | 1.42 |
Levered Free Cash Flow | 9.2 | 81.37 | 18.89 | 239.72 | 57.67 | 56.9 |
Unlevered Free Cash Flow | 17.73 | 96.62 | 34.94 | 248.98 | 58.36 | 57.23 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 23.12 | 23.22 | 26.81 | 17.57 | 3.02 | 2.11 |
Cash Income Tax Paid | 6.88 | 22.71 | 40.1 | 49 | 44.44 | 8.1 |
Change in Working Capital | -47.92 | -65.97 | -14.55 | -24.21 | -32.18 | -1.95 |